Product image of Lilinorm (Hydrocortisone) supplied by GNH India

Lilinorm

Active Ingredient:
Hydrocortisone
Origin:
EU

Lilinorm (Hydrocortisone)

Hydrocortisone, the active ingredient in Lilinorm, is a glucocorticoid presented as an oral tablet for oral use. It treats adrenal insufficiency and inflammatory conditions in patients who require systemic corticosteroid therapy.

GNH India supplies Lilinorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ace Pharmaceuticals Bv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hydrocortisone is a glucocorticoid that acts on the hypothalamic‑pituitary‑adrenal axis and inflammatory pathways.

  • Adrenal insufficiency: provides hormone replacement to restore cortisol levels.
  • Congenital adrenal hyperplasia: supplies glucocorticoid needed for metabolic control.
  • Inflammatory conditions: reduces systemic inflammation and associated symptoms in disorders such as rheumatoid arthritis or severe dermatitis.

How It Works

  • Hydrocortisone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and modulates gene transcription. This action suppresses pro‑inflammatory cytokine production, decreases leukocyte migration, and inhibits phospholipase A2, leading to reduced synthesis of prostaglandins and leukotrienes while also providing glucocorticoid hormone replacement.

Side Effects

Hydrocortisone may cause a range of adverse reactions, from mild to severe, depending on dose and duration of therapy.

Common Side Effects

  • Hyperglycemia: elevated blood sugar levels.
  • Fluid retention: swelling of extremities.
  • Hypertension: increased blood pressure.
  • Mood changes: irritability or euphoria.
  • Gastrointestinal upset: nausea or abdominal discomfort.
  • Weight gain: increased appetite and fat deposition.

Serious or Rare Side Effects

  • Adrenal suppression: reduced endogenous cortisol production.
  • Severe infection: heightened susceptibility to bacterial, viral, or fungal infections.
  • Cushingoid appearance: moon face, central obesity.
  • Osteoporosis: decreased bone mineral density.
  • Psychosis: hallucinations or severe mood disturbances.
  • Anaphylaxis: rare but life‑threatening allergic reaction.

Precautions & Warnings

Before initiating therapy with Hydrocortisone, clinicians should consider several safety measures.

  • Monitor blood glucose: adjust antidiabetic therapy as needed.
  • Assess blood pressure: watch for hypertension, especially in high‑risk patients.
  • Evaluate for infection: treat existing infections before starting.
  • Adjust dose in hepatic impairment: reduce dose if liver function is compromised.
  • Avoid abrupt discontinuation: taper gradually to prevent adrenal crisis.
  • Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Hydrocortisone can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

  • CYP3A4 inhibitors (e.g., ketoconazole): increase systemic exposure.
  • Anticoagulants (warfarin): may enhance anticoagulant effect.
  • NSAIDs: raise risk of gastrointestinal bleeding.
  • Live vaccines: reduced immunogenicity.
  • Diuretics: potentiate hypokalemia.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inducers (e.g., rifampin): decrease hydrocortisone levels.
  • Antidiabetic agents (insulin, oral hypoglycemics): may require dose adjustment.
  • Antihypertensives: possible reduction in blood‑pressure control.
  • HIV protease inhibitors: may increase glucocorticoid exposure.
  • Thyroid hormones: monitor for altered metabolism.

Frequently Asked Questions

Lilinorm contains hydrocortisone, a glucocorticoid used primarily for hormone replacement in adrenal insufficiency and to control systemic inflammation in conditions such as rheumatoid arthritis, severe dermatitis, and other inflammatory disorders.

Hydrocortisone binds to intracellular glucocorticoid receptors, influencing gene transcription to suppress inflammatory cytokines, reduce leukocyte activity, and inhibit enzymes involved in prostaglandin and leukotriene synthesis, while also providing the cortisol needed for normal metabolic function.

The appropriate dose of Lilinorm is determined by the prescribing clinician based on the patient’s condition, severity, age, and response to therapy. Dosage adjustments may be required for special populations or when used with interacting medications.

Safety data for hydrocortisone in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Lilinorm, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Lilinorm provides hydrocortisone, which has a relatively short half‑life and mimics natural cortisol, making it suitable for replacement therapy. Other corticosteroids such as prednisolone or dexamethasone have longer durations of action and greater potency, often chosen for different clinical scenarios.

Lilinorm should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid storing in humid or excessively hot environments.

Lilinorm is taken orally, typically as a tablet, and should be swallowed whole with water. The exact timing (e.g., with food or on an empty stomach) is directed by the prescribing clinician based on the therapeutic goal.

Serious risks include adrenal suppression, severe infections, Cushingoid changes, osteoporosis, and rare allergic reactions such as anaphylaxis. Patients should be monitored regularly for signs of these complications, especially during high‑dose or prolonged therapy.

Lilinorm is contraindicated in patients with known hypersensitivity to hydrocortisone or any excipients, uncontrolled systemic infections, and those receiving certain live vaccines. Caution is also advised for individuals with uncontrolled diabetes, hypertension, or severe osteoporosis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Hydrocortisone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT